These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30711676)

  • 1. Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia.
    Benussi A; Gazzina S; Premi E; Cosseddu M; Archetti S; Dell'Era V; Cantoni V; Cotelli MS; Alberici A; Micheli A; Benussi L; Ghidoni R; Padovani A; Borroni B
    Neurobiol Aging; 2019 Apr; 76():133-140. PubMed ID: 30711676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
    Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
    Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
    Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
    JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.
    Mutsaerts HJMM; Mirza SS; Petr J; Thomas DL; Cash DM; Bocchetta M; de Vita E; Metcalfe AWS; Shirzadi Z; Robertson AD; Tartaglia MC; Mitchell SB; Black SE; Freedman M; Tang-Wai D; Keren R; Rogaeva E; van Swieten J; Laforce R; Tagliavini F; Borroni B; Galimberti D; Rowe JB; Graff C; Frisoni GB; Finger E; Sorbi S; de Mendonça A; Rohrer JD; MacIntosh BJ; Masellis M;
    Brain; 2019 Apr; 142(4):1108-1120. PubMed ID: 30847466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia.
    Poos JM; Grandpierre LDM; van der Ende EL; Panman JL; Papma JM; Seelaar H; van den Berg E; van 't Klooster R; Bron E; Steketee R; Vernooij MW; Pijnenburg YAL; Rombouts SARB; van Swieten J; Jiskoot LC
    Neurology; 2022 Dec; 99(24):e2661-e2671. PubMed ID: 36288997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia.
    van der Ende EL; Morenas-Rodriguez E; McMillan C; Grossman M; Irwin D; Sanchez-Valle R; Graff C; Vandenberghe R; Pijnenburg YAL; Laforce R; Ber IL; Lleo A; Haass C; Suarez-Calvet M; van Swieten JC; Seelaar H
    Neurobiol Aging; 2021 Jul; 103():158.e1-158.e5. PubMed ID: 33896652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
    Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
    van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; de Jong FJ; Verberk IMW; Teunissen C; Rizopoulos D; Heller C; Convery RS; Moore KM; Bocchetta M; Neason M; Cash DM; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Carmela Tartaglia M; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Frisoni GB; Cappa S; Pijnenburg YAL; Rohrer JD; van Swieten JC;
    Lancet Neurol; 2019 Dec; 18(12):1103-1111. PubMed ID: 31701893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter changes in asymptomatic
    Popuri K; Dowds E; Beg MF; Balachandar R; Bhalla M; Jacova C; Buller A; Slack P; Sengdy P; Rademakers R; Wittenberg D; Feldman HH; Mackenzie IR; Hsiung GR
    Neuroimage Clin; 2018; 18():591-598. PubMed ID: 29845007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia.
    Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC
    Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.
    Cash DM; Bocchetta M; Thomas DL; Dick KM; van Swieten JC; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; de Mendonça A; Sorbi S; Rossor MN; Ourselin S; Rohrer JD;
    Neurobiol Aging; 2018 Feb; 62():191-196. PubMed ID: 29172163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular volume expansion in presymptomatic genetic frontotemporal dementia.
    Tavares TP; Mitchell DGV; Coleman K; Shoesmith C; Bartha R; Cash DM; Moore KM; van Swieten J; Borroni B; Galimberti D; Tartaglia MC; Rowe J; Graff C; Tagliavini F; Frisoni G; Cappa S; Laforce R; de Mendonça A; Sorbi S; Wallstrom G; Masellis M; Rohrer JD; Finger EC;
    Neurology; 2019 Oct; 93(18):e1699-e1706. PubMed ID: 31578297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia.
    Benussi A; Cosseddu M; Filareto I; Dell'Era V; Archetti S; Sofia Cotelli M; Micheli A; Padovani A; Borroni B
    Ann Neurol; 2016 Sep; 80(3):472-6. PubMed ID: 27438089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Pasternak M; Mirza SS; Luciw N; Mutsaerts HJMM; Petr J; Thomas D; Cash D; Bocchetta M; Tartaglia MC; Mitchell SB; Black SE; Freedman M; Tang-Wai D; Rogaeva E; Russell LL; Bouzigues A; van Swieten JC; Jiskoot LC; Seelaar H; Laforce R; Tiraboschi P; Borroni B; Galimberti D; Rowe JB; Graff C; Finger E; Sorbi S; de Mendonça A; Butler C; Gerhard A; Sanchez-Valle R; Moreno F; Synofzik M; Vandenberghe R; Ducharme S; Levin J; Otto M; Santana I; Strafella AP; MacIntosh BJ; Rohrer JD; Masellis M;
    Alzheimers Dement; 2024 May; 20(5):3525-3542. PubMed ID: 38623902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.
    Sellami L; Bocchetta M; Masellis M; Cash DM; Dick KM; van Swieten J; Borroni B; Galimberti D; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Finger E; de Mendonça A; Sorbi S; Warren JD; Rohrer JD; Laforce R;
    J Alzheimers Dis; 2018; 65(1):147-163. PubMed ID: 30010122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years.
    Bertrand A; Wen J; Rinaldi D; Houot M; Sayah S; Camuzat A; Fournier C; Fontanella S; Routier A; Couratier P; Pasquier F; Habert MO; Hannequin D; Martinaud O; Caroppo P; Levy R; Dubois B; Brice A; Durrleman S; Colliot O; Le Ber I;
    JAMA Neurol; 2018 Feb; 75(2):236-245. PubMed ID: 29197216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration.
    Tavares TP; Mitchell DGV; Coleman KK; Coleman BL; Shoesmith CL; Butler CR; Santana I; Danek A; Gerhard A; de Mendonca A; Borroni B; Tartaglia MC; Graff C; Galimberti D; Tagliavini F; Moreno F; Frisoni G; Rowe JB; Levin J; Van Swieten JC; Otto M; Synofzik M; Sanchez-Valle R; Vandenberghe R; Laforce RJ; Ghidoni R; Sorbi S; Ducharme S; Masellis M; Rohrer J; Finger E;
    J Neurol Neurosurg Psychiatry; 2020 Sep; 91(9):975-984. PubMed ID: 32769115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multimodal MRI-based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers.
    Feis RA; Bouts MJRJ; de Vos F; Schouten TM; Panman JL; Jiskoot LC; Dopper EGP; van der Grond J; van Swieten JC; Rombouts SARB
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1207-1214. PubMed ID: 31203211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities are seen only in
    Sudre CH; Bocchetta M; Cash D; Thomas DL; Woollacott I; Dick KM; van Swieten J; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Laforce R; Finger E; de Mendonça A; Sorbi S; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2017; 15():171-180. PubMed ID: 28529873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.